SC
CVS icon

Solstein Capital’s CVS Health CVS Stock Holding History

Solstein Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-465
Closed -$44K – 294
2022
Q3 		$44K Hold
465
– – 0.04% 159
2022
Q2 		$43K Hold
465
– – 0.03% 183
2022
Q1 		$47K Hold
465
– – 0.03% 199
2021
Q4 		$48K Hold
465
– – 0.03% 217
2021
Q3 		$39K Hold
465
– – 0.02% 254
2021
Q2 		$39K Hold
465
– – 0.05% 240
2021
Q1 		$35K Buy
+465
New +$33.9K 0.05% 221
2020
Q4 		– Sell
-492
Closed -$29K – 115
2020
Q3 		$29K Hold
492
– – 0.07% 156
2020
Q2 		$32K Hold
492
– – 0.08% 139
2020
Q1 		$29K Buy
492
+27
+6% +$1.8K 0.11% 106
2019
Q4 		$35K Buy
+465
New +$32.6K 0.07% 133

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Solstein Capital's CVS Position: Q4 2022 in Review

Solstein Capital sold out of CVS Health (CVS) in Q4 2022, closing a stake of 465 shares — an estimated $44K sold.

Solstein Capital first reported a position in CVS in Q4 2019 and held it in 11 quarters. The position peaked at $48K in Q4 2021. 2,405 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

  • Solstein Capital reported no remaining CVS Health position as of Q4 2022 after selling out during the quarter.
  • Solstein Capital sold 465 CVS Health shares in Q4 2022, an estimated $44K.
  • Solstein Capital first reported a position in CVS Health in Q4 2019 and held it in 11 quarters.
  • Solstein Capital's CVS Health position peaked at $48K in Q4 2021.
  • 2,405 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Solstein Capital's 13F filing for Q4 2022, filed 2 Feb 2023.